Pfizer : PFE

All Pfizer Articles

1482 Articles

Trey Thoelcke | Jul 31, 2012 at 7:59 AM EDT

U.S. Stock Futures Edge Higher as Investors Await Fed Action

U.S. stocks are set to open higher on the final day of July. All three indexes are expected to post…

Paul Ausick | Jul 31, 2012 at 7:36 AM EDT

Pfizer’s Profits Rise on Lower Revenues

Pfizer Inc. (NYSE: PFE) reported second-quarter adjusted earnings per share (EPS) of $0.62 and $15.06 billion in revenue this morning.…

Jon C. Ogg | Jul 30, 2012 at 12:33 PM EDT

Top Earnings Previews For This Week (AIG, ATVI, AWK, CMCSA, EA, FSLR, GMCR, KFT, PFE, PG, YELP)

Last week was a jam-packed week of earnings reports and this week has many key reports. We have provided earnings…

Jon C. Ogg | Jul 29, 2012 at 7:38 AM EDT

Ten Must-Watch Events for the Week Ahead

The week ahead is going to be a busy week. There are many traditional events to watch, but by now…

247sam | Jul 27, 2012 at 11:23 AM EDT

Amarin Shares Fall Despite Regulatory OK

Usually, shares of drug makers soar following the announcement that the Foood and Drug Administration approved a drug. Amarin Corp.…

Paul Ausick | Jul 24, 2012 at 7:21 AM EDT

Pfizer’s Alzheimer’s Drug Fails Trial

A new treatment for Alzheimer’s disease from Pfizer Inc. (NYSE: PFE) and partner Elan Corp. plc (NYSE: ELN) has failed…

Douglas A. McIntyre | Jul 24, 2012 at 6:41 AM EDT

Media Digest (7/24/2012) Reuters, WSJ, NYT, FT, Bloomberg

Carlyle (NASDAQ: CG) may buy a unit of United Technologies (NYSE: UTX). (Reuters) More factories move to the United States…

Douglas A. McIntyre | Jul 20, 2012 at 6:29 AM EDT

Ten Ways You’ll Know The Recession Is Over

When Gallup asked people about the state of the economy this spring, as a recovery appeared to have taken hold,…

Paul Ausick | Jul 18, 2012 at 10:56 AM EDT

Top 10 U.S. Drugs for 2012 First Quarter

Online drug research firm drugs.com today released its list of the top 100 selling drugs in the United States for…

Paul Ausick | Jul 18, 2012 at 8:34 AM EDT

Abbott Labs Stung by Foreign Exchange Rate

Abbott Laboratories (NYSE: ABT) reported second-quarter results this morning that beat the consensus estimate for earnings per share (EPS), but…

Jon C. Ogg | Jul 16, 2012 at 10:43 AM EDT

Looking for the Next Biotech Buyout After Two Drug and Biotech Deals

What usually happens when you get two mergers announced in drugs and biotech in the same day? Investors begin to…

Jon C. Ogg | Jul 10, 2012 at 7:35 AM EDT

Finding the Next Biotech M&A Targets (HGSI, GSK, AMLN, BMY, VRTX, CELG, CBST, AMRN, DNDN, BMRN, VVUS, ARNA, PCYC, VICL, MDGN, AFFX, THRX, RIGL)

More biotech mergers are on the way! That is the verdict of Wall St. There may be patent protection risks…

Jon C. Ogg | Jun 30, 2012 at 9:45 AM EDT

The Long Buyout Valuation of Amylin… A Higher Price Yet To Come?

Some mergers are very straight-forward, and others are just odd. Now we have an answer over whether or not Amylin…

Douglas A. McIntyre | Jun 29, 2012 at 6:50 AM EDT

The Best-Selling Products of All Time

Some products sell well when first introduced. Many more fail miserably. Very few of them sell so well that they…

Jon C. Ogg | Jun 5, 2012 at 8:16 AM EDT

Is Amylin Already At Full M&A Value Even Before It Is Announced? (AMLN, AZN, SNY, MRK, BMY, PFE)

Amylin Pharmaceuticals Inc. (NASDAQ: AMLN) is back in the rumor mill as far as a buyout, but this time the…

1 … 74 75 76 77 78 … 99

Pfizer : PFE

All Pfizer Articles

U.S. Stock Futures Edge Higher as Investors Await Fed Action

Pfizer’s Profits Rise on Lower Revenues

Top Earnings Previews For This Week (AIG, ATVI, AWK, CMCSA, EA, FSLR, GMCR, KFT, PFE, PG, YELP)

Ten Must-Watch Events for the Week Ahead

Amarin Shares Fall Despite Regulatory OK

Pfizer’s Alzheimer’s Drug Fails Trial

Media Digest (7/24/2012) Reuters, WSJ, NYT, FT, Bloomberg

Ten Ways You’ll Know The Recession Is Over

Top 10 U.S. Drugs for 2012 First Quarter

Abbott Labs Stung by Foreign Exchange Rate

Looking for the Next Biotech Buyout After Two Drug and Biotech Deals

Finding the Next Biotech M&A Targets (HGSI, GSK, AMLN, BMY, VRTX, CELG, CBST, AMRN, DNDN, BMRN, VVUS, ARNA, PCYC, VICL, MDGN, AFFX, THRX, RIGL)

The Long Buyout Valuation of Amylin… A Higher Price Yet To Come?

The Best-Selling Products of All Time

Is Amylin Already At Full M&A Value Even Before It Is Announced? (AMLN, AZN, SNY, MRK, BMY, PFE)

Why a $2.1 Million 401(k) Holder Is Moving From California to Nevada Before His First RMD at 73

Most Income Investors Have Never Heard of These 3 ETFs Paying Over 10 Percent Monthly

The Home Sale That Adds $5,880 a Year to a Retiree’s Medicare Premium Two Years Later

Why a $2.1 Million 401(k) Holder Is Moving From California to Nevada Before His First RMD at 73

The Home Sale That Adds $5,880 a Year to a Retiree's Medicare Premium Two Years Later

Why a $2.1 Million 401(k) Holder Is Moving From California to Nevada Before His First RMD at 73

Most Income Investors Have Never Heard of These 3 ETFs Paying Over 10 Percent Monthly

Pfizer : PFE

All Pfizer Articles

U.S. Stock Futures Edge Higher as Investors Await Fed Action

Pfizer’s Profits Rise on Lower Revenues

Top Earnings Previews For This Week (AIG, ATVI, AWK, CMCSA, EA, FSLR, GMCR, KFT, PFE, PG, YELP)

Ten Must-Watch Events for the Week Ahead

Amarin Shares Fall Despite Regulatory OK

Pfizer’s Alzheimer’s Drug Fails Trial

Media Digest (7/24/2012) Reuters, WSJ, NYT, FT, Bloomberg

Ten Ways You’ll Know The Recession Is Over

Top 10 U.S. Drugs for 2012 First Quarter

Abbott Labs Stung by Foreign Exchange Rate

Looking for the Next Biotech Buyout After Two Drug and Biotech Deals

Finding the Next Biotech M&A Targets (HGSI, GSK, AMLN, BMY, VRTX, CELG, CBST, AMRN, DNDN, BMRN, VVUS, ARNA, PCYC, VICL, MDGN, AFFX, THRX, RIGL)

The Long Buyout Valuation of Amylin… A Higher Price Yet To Come?

The Best-Selling Products of All Time

Is Amylin Already At Full M&A Value Even Before It Is Announced? (AMLN, AZN, SNY, MRK, BMY, PFE)

Why a $2.1 Million 401(k) Holder Is Moving From California to Nevada Before His First RMD at 73

Most Income Investors Have Never Heard of These 3 ETFs Paying Over 10 Percent Monthly

The Home Sale That Adds $5,880 a Year to a Retiree’s Medicare Premium Two Years Later

Featured Reads

Why a $2.1 Million 401(k) Holder Is Moving From California to Nevada Before His First RMD at 73

The Home Sale That Adds $5,880 a Year to a Retiree's Medicare Premium Two Years Later